MDM2 Gene Mutation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors (NCT03611868) | Ascentage Pharma Group Inc. | 2018-08-29 |
Track MDM2 Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.